Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

BBH vs. GNOM: which is better?

Bottom line

BBH vs GNOM: the short answer

BBH (VanEck Biotech ETF) and GNOM (Global X Genomics & Biotechnology ETF) are quite different portfolios: only about 23% of their top holdings (by weight) are shared.

But GNOM is far broader, holding 51 positions to 25 for BBH, so beyond the top names it adds exposure BBH doesn't have.

BBH is cheaper at 0.35% vs 0.5% — a difference of $15 a year per $10,000 invested.

Over five years, BBH returned +2.7% a year vs −13.3% for GNOM.

Updated Nov 19, 2026

BBH vs GNOM side by side

BBHGNOM
TypeETFETF
Fund familyVanEckGlobal X
CategoryTechnology SectorTechnology Sector
Expense ratio0.35%0.5%
Annual cost per $10k$35$50
10-yr cost on $10k (prospectus)$443$628
Max front loadNoneNone
12b-1 fee—0%
1-yr return+21.2%+19.0%
5-yr return (annualized)+2.7%−13.3%
10-yr return (annualized)+4.5%—
Best quarter+27.6%+38.8%
Worst quarter−18.2%−24.2%
Net assets (fund)$395.6M$55.8M
Number of holdings2551
Portfolio turnover19%34%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearBBHGNOMDifference
2025+21.2%+19.0%+2.2%
2024−4.4%−16.2%+11.8%
2023+3.9%−8.6%+12.5%
2022−15.1%−36.1%+21.0%
2021+11.8%−16.0%+27.8%
2020+22.1%+51.6%−29.6%

Source: Fund prospectus bar charts

Holdings overlap

8 of BBH's top 25 holdings also appear in GNOM's top 25.

Shared top holdings
HoldingBBHGNOM
Gilead Sciences Inc12.79%1.95%
Vertex Pharmaceuticals Inc9.10%3.95%
Natera Inc4.92%4.15%
Moderna Inc3.36%3.28%
Illumina Inc3.17%4.82%
BioNTech SE1.94%3.41%
Bio-Techne Corp1.54%3.41%
BioMarin Pharmaceutical Inc1.34%4.09%

Source: SEC Form N-PORT

BBH top 10

  1. Amgen Inc — 15.25%
  2. Gilead Sciences Inc — 12.79%
  3. Vertex Pharmaceuticals Inc — 9.10%
  4. Regeneron Pharmaceuticals Inc — 6.21%
  5. Revolution Medicines Inc — 5.27%
  6. Argenx SE — 4.97%
  7. Natera Inc — 4.92%
  8. IQVIA Holdings Inc — 4.31%
  9. Alnylam Pharmaceuticals Inc — 3.83%
  10. Biogen Inc — 3.63%

GNOM top 10

  1. Guardant Health, Inc. — 5.59%
  2. Illumina, Inc. — 4.82%
  3. Natera, Inc. — 4.15%
  4. Biomarin Pharmaceutical Inc. — 4.09%
  5. Arrowhead Pharmaceuticals, Inc. — 4.07%
  6. Legend Biotech Corp — 4.05%
  7. Praxis Precision Medicines Inc — 4.01%
  8. Twist Bioscience Corp — 3.97%
  9. Vertex Pharmaceuticals Incorporated — 3.95%
  10. CRISPR Therapeutics AG — 3.85%

FAQ

What is the difference between BBH and GNOM?
BBH (VanEck Biotech ETF) and GNOM (Global X Genomics & Biotechnology ETF) are quite different portfolios: only about 23% of their top holdings (by weight) are shared. But GNOM is far broader, holding 51 positions to 25 for BBH, so beyond the top names it adds exposure BBH doesn't have.
Which is cheaper, BBH or GNOM?
BBH has the lower expense ratio (0.35%).
Should I own both BBH and GNOM?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.